← FDA Drug Approvals (Drugs@FDA)

ROPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2018-06-15

Drug application

FDA Application #

ANDA207636

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROPIVACAINE HYDROCHLORIDE

Generic name

ROPIVACAINE HYDROCHLORIDE

Active ingredients

ROPIVACAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2018-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown